Show Filters

Searches all publications.

Search Term



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-08-15
    E.g., 2018-08-15



258282 items
9:31 AM, Aug 15, 2018  |  BC Innovations | Translation in Brief

Not your typical vaccine

In a July paper in the Proceedings of the National Academy of Sciences, University of Mississippi Medical Center researchers and colleagues identified conserved proteins in non-typeable Haemophilius influenzae that activate T cell responses to the...
8:53 AM, Aug 15, 2018  |  BC Innovations | Emerging Company Profile

Breaking bad biofilms

Synspira LLC is developing glycopolymers against pulmonary disorders by targeting three mechanisms that exacerbate pulmonary decline: bacteria themselves, the mucus and biofilms that protect them and inflammation that leads to lasting tissue damage. Synspira spun out...
3:35 PM, Aug 14, 2018  |  BC Extra | Company News

CVS to launch ICER-restricted formulary

CVS Health Corp. (NYSE:CVS) plans to offer a new formulary restricted to drugs deemed cost-effective by the Institute for Clinical and Economic Review (ICER). CVS believes the formulary will pressure manufacturers to moderate launch prices...
3:04 PM, Aug 14, 2018  |  BC Extra | Company News

Management tracks: Cheng departing Gilead as CMO

Gilead Sciences Inc. (NASDAQ:GILD) said CMO Andrew Cheng will leave the company, effective Sept. 7, after five months in the role to pursue another opportunity. Gilead did not say who would replace Cheng, who joined...
2:05 PM, Aug 14, 2018  |  BC Extra | Financial News

Loncar's China biopharma fund to list on NASDAQ Wednesday

The Loncar China BioPharma ETF (NASDAQ:CHNA) is scheduled to begin trading on NASDAQ on Wednesday. The ETF bundles the companies of the Loncar China BioPharma Index (LCHINA) under one security that trades in the U.S. Brad...
10:32 AM, Aug 14, 2018  |  BC Extra | Company News

Motif's antibiotic gets Priority Review

Motif Bio plc (LSE:MTFB; NASDAQ:MTFB) said FDA accepted and granted Priority Review to an NDA for iclaprim (MTF-100) to treat acute bacterial skin and skin structure infections (ABSSSIs). Its PDUFA date is Feb. 13, 2019. The...
9:34 AM, Aug 14, 2018  |  BC Innovations | Translation in Brief

Primate predictions

A team at Illumina Inc. (NASDAQ:ILMN) has developed an AI algorithm that will help identify pathogenic mutations from genome sequencing analyses by including non-human primate data in the training data set, and the approach could...
7:02 AM, Aug 14, 2018  |  BC Extra | Company News

Juvenescence, partners form anti-aging biotech

Juvenescence Ltd. (Douglas, Isle of Man), Insilico Medicine Inc. (Baltimore, Md.) and the Buck Institute for Research on Aging (Novato, Calif.) partnered to form anti-aging company Napa Therapeutics Ltd. (Tortola, British Virgin Islands). Napa will use...
4:04 PM, Aug 13, 2018  |  BC Extra | Politics & Policy

Trump signs expanded CFIUS jurisdiction into law

President Donald Trump signed into law Monday the Foreign Investment Risk Review Modernization Act (FIRRMA), which expands the jurisdiction of the Committee on Foreign Investment in the United States (CFIUS) to cover "foundational and emerging...
2:03 PM, Aug 13, 2018  |  BC Extra | Company News

Management tracks: FDA, Allergan

Patrick Frey will depart as chief of staff in FDA’s Office of New Drugs (OND) on Aug. 24 to become director of global regulatory policy and R&D at Amgen Inc. (NASDAQ:AMGN). Khushboo Sharma becomes OND’s...